Abbot Financial Management’s Invesco Biotechnology & Genome ETF PBE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$816K Sell
12,725
-475
-4% -$30.4K 0.38% 77
2025
Q1
$837K Sell
13,200
-150
-1% -$9.52K 0.43% 63
2024
Q4
$888K Hold
13,350
0.44% 61
2024
Q3
$932K Sell
13,350
-1,150
-8% -$80.3K 0.47% 57
2024
Q2
$940K Hold
14,500
0.5% 55
2024
Q1
$938K Sell
14,500
-500
-3% -$32.4K 0.52% 57
2023
Q4
$988K Sell
15,000
-300
-2% -$19.8K 0.59% 49
2023
Q3
$873K Sell
15,300
-200
-1% -$11.4K 0.59% 50
2023
Q2
$950K Sell
15,500
-225
-1% -$13.8K 0.61% 49
2023
Q1
$987K Hold
15,725
0.66% 47
2022
Q4
$998K Sell
15,725
-700
-4% -$44.4K 0.68% 47
2022
Q3
$968K Sell
16,425
-375
-2% -$22.1K 0.69% 46
2022
Q2
$970K Sell
16,800
-500
-3% -$28.9K 0.59% 53
2022
Q1
$1.07M Sell
17,300
-450
-3% -$27.9K 0.52% 54
2021
Q4
$1.26M Sell
17,750
-1,350
-7% -$96.1K 0.56% 52
2021
Q3
$1.43M Hold
19,100
0.65% 46
2021
Q2
$1.48M Sell
19,100
-50
-0.3% -$3.87K 0.65% 44
2021
Q1
$1.41M Sell
19,150
-50
-0.3% -$3.69K 0.64% 44
2020
Q4
$1.35M Hold
19,200
0.78% 43
2020
Q3
$1.09M Sell
19,200
-400
-2% -$22.6K 0.71% 43
2020
Q2
$1.14M Hold
19,600
0.79% 41
2020
Q1
$911K Sell
19,600
-2,000
-9% -$93K 0.74% 43
2019
Q4
$1.21M Sell
21,600
-400
-2% -$22.3K 0.76% 40
2019
Q3
$1.04M Hold
22,000
0.74% 41
2019
Q2
$1.18M Sell
22,000
-700
-3% -$37.5K 0.85% 38
2019
Q1
$1.25M Sell
22,700
-225
-1% -$12.4K 0.97% 34
2018
Q4
$1.08M Hold
22,925
0.95% 35
2018
Q3
$1.36M Sell
22,925
-125
-0.5% -$7.43K 1.01% 34
2018
Q2
$1.26M Buy
23,050
+250
+1% +$13.7K 1% 35
2018
Q1
$1.12M Sell
22,800
-425
-2% -$20.9K 0.9% 39
2017
Q4
$1.1M Hold
23,225
0.87% 44
2017
Q3
$1.11M Hold
23,225
0.92% 41
2017
Q2
$1.06M Buy
+23,225
New +$1.06M 0.95% 38